INPPL1 and cancer: SHIP2 has been widely studied in insulin resistance [21, 27, 28], obesity [22], and cancer [29], and recently, it was reported that mutations in INPPL1 cause opsismodysplasia, a rare autosomal recessive severe skeletal dysplasia [30, 31].